Bouza E - Search Results

1

In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates.

García-Garrote F, Cercenado E, Alcalá L, Bouza E. García-Garrote F, et al. Among authors: bouza e. Antimicrob Agents Chemother. 1998 Sep;42(9):2452-5. doi: 10.1128/AAC.42.9.2452. Antimicrob Agents Chemother. 1998. PMID: 9736584 Free PMC article.

2

Antimicrobial resistance of Salmonella isolates in a Spanish hospital.

Muńoz P, Díaz MD, Rodríguez-Créixems M, Cercenado E, Peláez T, Bouza E. Muńoz P, et al. Among authors: bouza e. Antimicrob Agents Chemother. 1993 May;37(5):1200-2. doi: 10.1128/AAC.37.5.1200. Antimicrob Agents Chemother. 1993. PMID: 8517717 Free PMC article.

3

Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria.

Sánchez-Carrillo C, Cotarelo M, Cercenado E, Vicente T, Blázquez R, Bouza E. Sánchez-Carrillo C, et al. Among authors: bouza e. J Antimicrob Chemother. 1996 Jan;37(1):151-4. doi: 10.1093/jac/37.1.151. J Antimicrob Chemother. 1996. PMID: 8647757

4

In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates.

Alcalá L, Cercenado E, García-Garrote F, Bouza E. Alcalá L, et al. Among authors: bouza e. Diagn Microbiol Infect Dis. 1999 Jan;33(1):27-31. doi: 10.1016/s0732-8893(98)00129-1. Diagn Microbiol Infect Dis. 1999. PMID: 9990472

5

Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group.

Bouza E, Garcia-Garrote F, Cercenado E, Marin M, Diaz MS. Bouza E, et al. Antimicrob Agents Chemother. 1999 Apr;43(4):981-2. doi: 10.1128/AAC.43.4.981. Antimicrob Agents Chemother. 1999. PMID: 10103217 Free PMC article.

6

Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.

Cotarelo M, Catalán P, Sánchez-Carrillo C, Menasalvas A, Cercenado E, Tenorio A, Bouza E. Cotarelo M, et al. Among authors: bouza e. J Antimicrob Chemother. 1999 Nov;44(5):705-8. doi: 10.1093/jac/44.5.705. J Antimicrob Chemother. 1999. PMID: 10552991

7

Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci.

Garcia-Garrote F, Cercenado E, Bouza E. Garcia-Garrote F, et al. Among authors: bouza e. J Clin Microbiol. 2000 Jun;38(6):2108-11. doi: 10.1128/JCM.38.6.2108-2111.2000. J Clin Microbiol. 2000. PMID: 10834961 Free PMC article.

8

In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs.

Ruiz-Serrano MJ, Alcalá L, Martínez L, Díaz M, Marín M, González-Abad MJ, Bouza E. Ruiz-Serrano MJ, et al. Among authors: bouza e. Antimicrob Agents Chemother. 2000 Sep;44(9):2567-8. doi: 10.1128/AAC.44.9.2567-2568.2000. Antimicrob Agents Chemother. 2000. PMID: 10952620 Free PMC article.

9

In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates.

Cercenado E, García-Garrote F, Bouza E. Cercenado E, et al. Among authors: bouza e. J Antimicrob Chemother. 2001 Jan;47(1):77-81. doi: 10.1093/jac/47.1.77. J Antimicrob Chemother. 2001. PMID: 11152434

10

In vitro activity of new quinolones against Clostridium difficile.

Alonso R, Peláez T, González-Abad MJ, Alcalá L, Muñoz P, Rodríguez-Créixems M, Bouza E. Alonso R, et al. Among authors: bouza e. J Antimicrob Chemother. 2001 Feb;47(2):195-7. doi: 10.1093/jac/47.2.195. J Antimicrob Chemother. 2001. PMID: 11157906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,045 results

Search Page

Filters